# DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery

> **NCT04281862** · PHASE4 · UNKNOWN · sponsor: **Vance Thompson Vision** · enrollment: 20 (estimated)

## Conditions studied

- Refractive Surgery

## Interventions

- **DRUG:** Dextenza 0.4Mg Ophthalmic Insert
- **DRUG:** Topical Prednisolone

## Key facts

- **NCT ID:** NCT04281862
- **Lead sponsor:** Vance Thompson Vision
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-23
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04281862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04281862, "DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04281862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*